tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ONCY Stock Latest News

Oncolytics Biotech Reports Q3 2025 Financial Results
Company AnnouncementsOncolytics Biotech Reports Q3 2025 Financial Results
20h ago
ONCY
Oncolytics Biotech Reschedules Shareholder Meeting Amid SEC Delays
PremiumCompany Announcements
Oncolytics Biotech Reschedules Shareholder Meeting Amid SEC Delays
7d ago
6K
ONCY
Positive Buy Rating for Oncolytics Biotech Following FDA Endorsement of Pelareorep Phase 3 Trial
PremiumRatings
Positive Buy Rating for Oncolytics Biotech Following FDA Endorsement of Pelareorep Phase 3 Trial
8d ago
ONCY
Oncolytics Biotech Aligns with FDA for Pivotal Pancreatic Cancer Study
PremiumCompany Announcements
Oncolytics Biotech Aligns with FDA for Pivotal Pancreatic Cancer Study
8d ago
6K
ONCY
Oncolytics aligns with FDA on pelareorep study design
PremiumThe Fly
Oncolytics aligns with FDA on pelareorep study design
8d ago
ONCY
Oncolytics Biotech: Strategic Advancements and Promising Clinical Data Justify Buy Rating
PremiumRatingsOncolytics Biotech: Strategic Advancements and Promising Clinical Data Justify Buy Rating
9d ago
ONCY
Oncolytics Biotech Forms Advisory Board to Advance Pelareorep in GI Cancers
Premium
Company Announcements
Oncolytics Biotech Forms Advisory Board to Advance Pelareorep in GI Cancers
10d ago
ONCY
Oncolytics price target raised to $10 from $5 at H.C. Wainwright
Premium
The Fly
Oncolytics price target raised to $10 from $5 at H.C. Wainwright
11d ago
ONCY
Oncolytics Biotech Reports Increased Q3 Loss Amid Rising Expenses
PremiumCompany Announcements
Oncolytics Biotech Reports Increased Q3 Loss Amid Rising Expenses
15d ago
6K
ONCY
Is ONCY a Buy, Before Earnings?
PremiumPre-Earnings
Is ONCY a Buy, Before Earnings?
18d ago
ONCY
Oncolytics Biotech Forms Advisory Board to Advance GI Cancer Treatment
PremiumCompany Announcements
Oncolytics Biotech Forms Advisory Board to Advance GI Cancer Treatment
23d ago
6K
ONCY
Promising Potential of Oncolytics Biotech’s Pelareorep in SCAC: Buy Rating with $5 Price Target
PremiumRatings
Promising Potential of Oncolytics Biotech’s Pelareorep in SCAC: Buy Rating with $5 Price Target
29d ago
ONCY
Oncolytics Biotech Reports Promising Anal Cancer Data with Pelareorep
PremiumCompany AnnouncementsOncolytics Biotech Reports Promising Anal Cancer Data with Pelareorep
1M ago
6K
ONCY
Oncolytics reports updated results from study of pelareorep plus atezolizumab
Premium
The Fly
Oncolytics reports updated results from study of pelareorep plus atezolizumab
1M ago
ONCY
Oncolytics Biotech Plans Jurisdiction Shift to Nevada
Premium
Company Announcements
Oncolytics Biotech Plans Jurisdiction Shift to Nevada
1M ago
ONCY
Oncolytics Biotech Highlights Pelareorep’s Potential in Cancer Therapy
PremiumCompany Announcements
Oncolytics Biotech Highlights Pelareorep’s Potential in Cancer Therapy
2M ago
6K
ONCY
Oncolytics Biotech Advances Pancreatic Cancer Trial with Innovative Design
PremiumCompany Announcements
Oncolytics Biotech Advances Pancreatic Cancer Trial with Innovative Design
2M ago
ONCY
Positive Outlook for Oncolytics Biotech Amidst Strategic Advancements and Sector Growth
PremiumRatings
Positive Outlook for Oncolytics Biotech Amidst Strategic Advancements and Sector Growth
2M ago
ONCY
Oncolytics Biotech Expands GOBLET Study to U.S., Shows Promising Results
PremiumCompany Announcements
Oncolytics Biotech Expands GOBLET Study to U.S., Shows Promising Results
2M ago
ONCY
Oncolytics provides update on study of pelareorep in gastrointestinal cancers
PremiumThe FlyOncolytics provides update on study of pelareorep in gastrointestinal cancers
2M ago
ONCY
Promising Outlook for Oncolytics Biotech: Buy Rating Backed by Strong Clinical Data and Strategic Catalysts
Premium
Ratings
Promising Outlook for Oncolytics Biotech: Buy Rating Backed by Strong Clinical Data and Strategic Catalysts
2M ago
ONCY
Oncolytics Biotech Reports Promising Results in Metastatic Colorectal Cancer Studies
Premium
Company Announcements
Oncolytics Biotech Reports Promising Results in Metastatic Colorectal Cancer Studies
3M ago
6K
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >